Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Terves is a materials science company specializing in the development and manufacturing of dissolvable and reactive metals, primarily for the energy and biomedical sectors. The company is widely recognized for its TervAlloy line of high-strength, dissolvable magnesium alloys, which are used to create temporary components that disappear after their functional life. In the healthcare space, Terves focuses on bioresorbable magnesium materials for medical implants, such as orthopedic screws and cardiovascular stents, designed to be absorbed by the body to eliminate the need for follow-up removal surgeries. The company was acquired by Hunting PLC in 2023 to expand its portfolio of advanced materials and technology solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Terves.